Anaesthesia & intensive care medicine
Volume 10, Issue 4 , Pages 176-178, April 2009

Haematological problems in intensive care

Girish Balikai, MBBS, MD, MRCP (UK), is a Specialist Registrar in Haematology at the Derriford Hospital, Plymouth, UK. He qualified in India and trained in general medicine. He is currently working towards membership of Royal college of Pathology, and is interested in coagulation and chronic lymphoproliferative diseases. Conflicts of interest: none declared

Nimish KN Shah, MBBCH, MRCP, is a Specialist Registrar in Haematology at Derriford Hospital, Plymouth. He qualified in University College Dublin, Ireland. He is interested in malignant haematology. Conflicts of interest: none declared

Timothy JC Nokes, MBBS, FRCP, FRCPath, is a Consultant Haematologist at Derriford Hospital, Plymouth. He qualified from The Royal Free Hospital and trained in Haematology at University College Hospital, London, UK. He has a sub-speciality interest in haemostasis and thrombosis, with a particular research interest in platelets. Conflicts of interest: none declared

Abstract 

Anaemia, thrombocytopenia and coagulation problems are common haematological abnormalities encountered regularly in intensive care units (ICUs). The causes of all are multifactorial, making diagnosis of the problem difficult. The causes of anaemia range from blood loss to myelosuppression. Various studies have shown that lower haemoglobin (Hb) threshold levels (7 g/dl) for transfusion are appropriate and even safer than higher levels in haemodynamically stable patients. However, the transfusion trigger should be decided in individual patients depending on their comorbidities. Every effort should be made to find and treat the cause of thrombocytopenia, which may be life-threatening and is, in itself, a poor prognostic feature in ICU patients. Sepsis and drugs are the most frequently encountered causes of thrombocytopenia. Management should include treatment of the underlying cause, together with platelet transfusion, which may be life-saving but also contraindicated in some causes of significant thrombocytopenia. Coagulation defects range from simple abnormal clotting tests to frank disseminated intravascular coagulation (DIC). Prothrombin time (PT) and activated partial thromboplastin time (APTT) are the most commonly performed tests to screen for causes of bleeding. However, they are not wholly predictive of the bleeding diathesis. Management of coagulation abnormalities is to treat the underlying cause and in the bleeding patient to consider the use of blood products such as fresh frozen plasma (FFP) or a prothrombin complex concentrate (PCC).

Keywords: anaemia, coagulation problems, critical care, DIC, FFP, haematological problems, intensive care, platelets, red-blood-cell transfusion, thrombocytopenia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1472-0299(09)00002-2

doi:10.1016/j.mpaic.2009.01.001

Anaesthesia & intensive care medicine
Volume 10, Issue 4 , Pages 176-178, April 2009